Call us 24/7

Neuroendocrine Tumor Clinical Program

Our program

The clinicians in the Neuroendocrine Tumor Clinical Program at Cancer Treatment Centers of America® (CTCA), Chicago, have extensive experience in diagnosing and treating neuroendocrine tumors (NETs), sometimes known as carcinoid tumors. Our doctors work with referring physicians and their patients to help treat and manage this rare disease, which develops when abnormal growths begin to form in neuroendocrine cells. NETs are staged using diagnostics including NETSPOT, an imaging agent that helps locate somatostatin receptor-positive NETs and determine treatment options. Our cancer experts then collaborate with one another, and with the patient, as part of a multidisciplinary team, to develop a personalized treatment plan tailored to each patient’s individual needs.

NET treatment options

The NET Clinical Program provides patients a comprehensive array of treatment options. The type, location and extent of the disease dictate which treatments may be available.

Treatment options may include:

  • Surgery options include minimally invasive procedures using laparoscopy or laparotomy, either to remove the entire tumor or to reduce its mass if it cannot be completely removed. Mesenteric resections for small bowel tumors and cytoreductive surgery may be recommended for advanced-stage disease.
  • Immunotherapy treatments use the drug interferon, which helps stimulate the immune system.
  • Targeted therapy drugs attack certain areas of the cancer cell or its environment (including genes and proteins) that may be responsible for the tumor’s growth.
  • Chemotherapy drugs are designed to interfere with the growth of cancer cells in order to destroy them.
  • Interventional radiology uses both catheter- and needle-based therapies.

Peptide receptor radionuclide therapy combines a cell-targeting protein (or peptide) with a radionuclide (or radioactive material), and is given intravenously to deliver a high dose of radiation to the tumors.

Because of the complexity and diversity of NETs, our experts collaborate daily, allowing them to recommend a personalized care plan.

Depending on each patient’s unique diagnosis and needs, members of the NET care team may include surgical, medical or radiation oncologists, gastroenterologists, interventional radiologists, endocrinologists, pathologists, pain management physicians, dietitians, naturopathic oncology providers, mind-body therapists and other trained clinicians.

critical care

Meet our team

Our NET team brings together clinicians from multiple disciplines, all focused on caring for patients with neuroendocrine tumors. In addition to the medical professionals below, a trained team of nurses and nuclear medicine technologists assist throughout the continuum of care.

Jeffery Choh - Director of Interventional Radiology

Jeffery Choh

Medical Director of Radiology, CTCA Chicago

Hatem Halabi - Assistant Director of the GI Cancer Institute

Hatem Halabi

Vice Chair, CTCA Department of Surgery

Kenny S. Yoo - Interventional Radiologist

Kenny S. Yoo

Director, Interventional Radiology, CTCA Chicago

Revathi Suppiah - Medical Oncologist

Revathi Suppiah

Medical Oncologist, CTCA Chicago

Chicago Hospital

Where we are located

CTCA Chicago

Neuroendocrine Tumor Clinical Program
2520 Elisha Ave.
Zion, IL 60099
New patients: 855-635-3218 | Existing Patients: (847) 510-CTCA

Get directions | Contact a live agent